Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, P.R.China.
Nanjing University of Chinese Medicine, Nanjing 210023, P.R. China.
J Ethnopharmacol. 2019 Dec 5;245:112126. doi: 10.1016/j.jep.2019.112126. Epub 2019 Aug 14.
Pulmonary fibrosis (PF) is a progressive disease characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma, associated with significant morbidity. Few effective drugs have been developed to reverse PF or even halt the disease progression. Yangfei Huoxue Decoction (YHD), a Traditional Chinese Medicine, which consisted of Astragalus membranacus(AM), Glehnia littoralis(GL), Schisandra chinensis(SC), Salvia miltiorrhiza Bunge(SB), Reynoutria japonica(RJ), Ligusticum chuanxiong(LX), and Euonymus alatus(EA) , has been used in China for the treatment of PF for many years with remarkable efficacy. According to the clinic observation of the results, we conducted experiments on animals, the process of BLM-induced pulmonary fibrosis in rats was interfered by YHD, through the detection of pulmonary fibrosis rats' blood cells and plasma, we selected the related molecules that may exert proinflammatory(IL-1β), promote angiogenesis(vascular endothelial growth factor ,VEGF). For further explicitly research, we should know what the chemical composition the prescription (YHD) contains and what the related bioactive components have. In accordance with in-house library and evaluating the characteristic MS fragmentation patterns, the schisandra chinensis methanol, lignin, flavonol, polyphenol, tanshinone, salvianolic acid, anthraquinone, ligustrazine, etc. had a retardant and inhibitory effect on the development and formation of pulmonary fibrosis. These results will aid in the quality control of YHD, as well as provide fundamental data for further pharmaco-mechanisms studies.
To discover the pulmonary immune related bioactive components of YHD.
Animal Experiment:144 SD rats, based on the principles of randomization divided into eight groups, Control group, bleomycin(BLM) group, BLM + dexamethasone(BLM + DXM) group, BLM + Yangfei(YF) group, BLM + Huoxue(HX) group, BLM + high-doseYHD(YHD-H) group, BLM + medium-doseYHD(YHD-M) group, and BLM + low-doseYHD(YHD-L) group, each group of 18 rats. After endotracheal administration of Bleomycin by tracheotomy, rats were sacrificed on day 7, day 14 and day 28, blood and plasma were taken at the same time. Respectively, the VEGF, an immune molecule associated with angiogenesis, and IL-1β in plasma were detected by ELISA at three time periods. Component testing: 100 g YHD were constituted of SB 15 g, LX 12 g, EA 10 g, RJ 15 g, AM 20 g, GL 20 g and SC 8 g. All herbs were obtained from Beijing Tong Ren Tang (Group) Co ltd. The voucher specimens were identified by Prof. Jiening Gong (Nanjing University of Chinese Medicine). YHD were extracted by sonication with 1 L ethanol/water (70:30, v/v) for two cycle (1 h per cycle) at room temperature. The combined extracts were filtered, condensed, and reconstituted with 50 mL methanol before analysis. Standard Cianidanol, Ferulic Acid, Polydatin, Calycosin 7-O-glucoside, Tanshinone IIA, Salvianolic acid B, Schizandrol A, and Isoimperatorin were prepared in methanol. After centrifuging at 20,000 rpm for 10 min, 4 μL supernatant was injected into the Ultra-Performance Liquid Chromatography coupled with Quadrupole Time-of-Flight tandem mass spectrometry (UPLC/QTOF-MS) combined with UNIFI informatics platform for analysis.
The experiment results revealed that the vascularized VEGF, inflammatory factor expression of IL-1β was restrained by YHD. The UPLC/QTOF-MS method, an automatic database screening platform and the characteristic MS fragmentation patterns have efficiently facilitated the post data process, so we test for the identification of major components in YHD by this technology, more than seven or more active ingredients, the results showed that YHD contained a total of 55 components, including 11 lignans, 12 flavonoids, 7 tanshinones, 9 organic acid, 5 polyphenols, 4 anthraquinones, 5 senkyunolides and 2 others. Based on this, we can ensure the discovery and analysis of biologically active compounds in YHD, as well as provide a reference for the quality evaluation. We expect the method presented here could be applied to other multi-component TCM formula. In addition, we can conduct more in-depth research, such as mechanism research, molecular detection, gene target and so on.
肺纤维化(PF)是一种以肺实质中纤维组织异常积累为特征的进行性疾病,伴有显著的发病率。目前已经开发出少数几种有效的药物来逆转 PF 甚至阻止疾病的进展。 杨肺活血汤(YHD)是一种中药,由黄芪(AM)、沙棘(GL)、五味子(SC)、丹参(SB)、虎杖(RJ)、川芎(LX)和独活(EA)组成,多年来一直在中国用于治疗 PF,疗效显著。根据临床观察结果,我们在动物身上进行了实验,通过检测肺纤维化大鼠的血细胞和血浆,我们发现 YHD 可以干预博莱霉素(BLM)诱导的大鼠肺纤维化过程,选择可能发挥促炎(IL-1β)、促进血管生成(血管内皮生长因子,VEGF)作用的相关分子。为了进一步明确研究,我们应该知道处方(YHD)中含有哪些化学成分,以及相关的生物活性成分有哪些。根据内部库和评估特征 MS 碎片模式,五味子甲醇、木质素、类黄酮、多酚、丹参酮、丹参酸、蒽醌、川芎嗪等对肺纤维化的发展和形成有延缓和抑制作用。这些结果将有助于 YHD 的质量控制,并为进一步的药物机制研究提供基础数据。
发现 YHD 的肺免疫相关生物活性成分。
动物实验:144 只 SD 大鼠,根据随机化原则分为 8 组,对照组、博莱霉素(BLM)组、BLM+地塞米松(BLM+DXM)组、BLM+杨肺(YF)组、BLM+活血(HX)组、BLM+高剂量 YHD(YHD-H)组、BLM+中剂量 YHD(YHD-M)组和 BLM+低剂量 YHD(YHD-L)组,每组 18 只大鼠。经气管切开气管内给药博莱霉素后,于第 7、14 和 28 天处死大鼠,同时取血和血浆。分别采用 ELISA 法检测血浆中与血管生成相关的免疫分子 VEGF 和 IL-1β。成分测试:100g YHD 由 SB 15g、LX 12g、EA 10g、RJ 15g、AM 20g、GL 20g 和 SC 8g 组成。所有草药均购自北京同仁堂(集团)有限公司。凭证标本由 Gong Jiening 教授(南京中医药大学)鉴定。YHD 通过超声提取 1L 乙醇/水(70:30,v/v),每个循环 1 小时,共两个循环,在室温下进行。合并提取液过滤、浓缩,然后用 50mL 甲醇重新配制,再进行分析。标准的丹参酮 IIA、阿魏酸、虎杖苷、芒柄花苷、丹参酮 IIA、丹参酸 B、五味子醇 A、异欧前胡素在甲醇中制备。在 20000rpm 离心 10min 后,取 4μL 上清液注入超高效液相色谱-四极杆飞行时间串联质谱(UPLC/QTOF-MS)联用 UNIFI 信息平台进行分析。
实验结果表明,YHD 抑制了血管生成的 VEGF、IL-1β炎症因子的表达。UPLC/QTOF-MS 方法、自动数据库筛选平台和特征 MS 碎片模式有效地促进了后续的数据处理,因此我们通过该技术测试了 YHD 中主要成分的鉴定,发现了 7 种以上的活性成分,结果表明 YHD 含有 55 种成分,包括 11 种木脂素、12 种黄酮类化合物、7 种丹参酮、9 种有机酸、5 种多酚、4 种蒽醌、5 种 Senkyunolide 和 2 种其他化合物。有了这些,我们可以确保对 YHD 中生物活性化合物的发现和分析,并为质量评估提供参考。我们希望这里提出的方法可以应用于其他多成分中药配方。此外,我们可以进行更深入的研究,如机制研究、分子检测、基因靶点等。